Contract Bidding Open For Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered in PUNE, MAHARASHTRA
Bid Publish Date
23-May-2025, 5:00 pm
Bid End Date
13-Jun-2025, 5:00 pm
Value
₹1,13,49,160
Location
Progress
RAQuantity
79349
Categories
9
Public procurement opportunity for Indian Army Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray, isoflurane bottle of 250 ml, RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm, Pegylated GCSF 6 mg Inj, HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN, HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN, NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE, Menotrophin 5U FSH 75 ULH Inj, USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML, Inj Posaconazole 300 mg, THIOTEPA 15 MG INJ in PUNE, MAHARASHTRA. Quantity: 79349 issued by. Submission Deadline: 13-06-2025 17: 00: 00. View full details and respond.
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Item Category
Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray , isoflurane bottle of 250 ml , RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm , Pegylated GCSF 6 mg Inj , HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN , HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN , NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE , Menotrophin 5U FSH 75 ULH Inj , USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML , Inj Posaconazole 300 mg , THIOTEPA 15 MG INJ
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-7858035.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
11 Items Sign in to view GEM price trends Sign in for GEM prices
Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray
Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray
isoflurane bottle of 250 ml
isoflurane bottle of 250 ml
RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm
RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm
Pegylated GCSF 6 mg Inj
Pegylated GCSF 6 mg Inj
HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN
HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN
HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN
HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN
NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE
NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE
Menotrophin 5U FSH 75 ULH Inj
Menotrophin 5U FSH 75 ULH Inj
USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML
USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML
Inj Posaconazole 300 mg
Inj Posaconazole 300 mg
THIOTEPA 15 MG INJ
THIOTEPA 15 MG INJ
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray | Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray | 1,330 | 1330 | gemdglp@2024 | 30 | |
| 2 | isoflurane bottle of 250 ml | isoflurane bottle of 250 ml | 900 | 900 | gemdglp@2024 | 30 | |
| 3 | RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm | RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm | 150 | 150 | gemdglp@2024 | 30 | |
| 4 | Pegylated GCSF 6 mg Inj | Pegylated GCSF 6 mg Inj | 360 | 360 | gemdglp@2024 | 30 | |
| 5 | HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | 5,900 | 5900 | gemdglp@2024 | 30 | |
| 6 | HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | 7,600 | 7600 | gemdglp@2024 | 30 | |
| 7 | NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE | NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE | 60,000 | 60000 | gemdglp@2024 | 30 | |
| 8 | Menotrophin 5U FSH 75 ULH Inj | Menotrophin 5U FSH 75 ULH Inj | 3,000 | 3000 | gemdglp@2024 | 30 | |
| 9 | USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML | USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML | 12 | 12 | gemdglp@2024 | 30 | |
| 10 | Inj Posaconazole 300 mg | Inj Posaconazole 300 mg | 72 | 72 | gemdglp@2024 | 30 | |
| 11 | THIOTEPA 15 MG INJ | THIOTEPA 15 MG INJ | 25 | 25 | gemdglp@2024 | 30 |
Reverse Auction Schedule
Start
27-Jul-2025, 11:00 am
End
29-Jul-2025, 10:00 am
Duration: 47 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 12-06-2025 18:40:25 | |
| 2 | ********** Under PMA | - | 13-06-2025 13:01:35 | |
| 3 | ********** Under PMA | - | 26-05-2025 13:40:25 | |
| 4 | ********** Under PMA | - | 13-06-2025 14:37:14 | |
| 5 | ********** Under PMA | - | 13-06-2025 16:51:10 | |
| 6 | ********** Under PMA | - | 28-05-2025 15:46:43 | |
| 7 | ********** Under PMA | - | 13-06-2025 15:10:16 | |
| 8 | ********** Under PMA | - | 13-06-2025 14:20:59 | |
| 9 | ********** Under PMA | - | 13-06-2025 15:48:50 | |
| 10 | ********** Under PMA | - | 12-06-2025 17:14:05 | |
| 11 | ********** Under PMA | - | 13-06-2025 14:17:24 | |
| 12 | ********** Under PMA | - | 12-06-2025 17:51:54 | |
| 13 | ********** Under PMA | - | 13-06-2025 12:44:25 | |
| 14 | ********** Under PMA | - | 13-06-2025 14:59:47 | |
| 15 | ********** Under PMA | - | 12-06-2025 19:48:59 | |
| 16 | ********** Under PMA | - | 13-06-2025 16:50:06 | |
| 17 | ********** Under PMA | - | 13-06-2025 11:15:09 | |
| 18 | ********** Under PMA | - | 11-06-2025 10:32:22 |
Frequently Asked Questions
Key insights about MAHARASHTRA tender market
What are the eligibility requirements for participating in the tender?
The eligibility requirements include being a registered entity, possessing relevant industry certifications, and demonstrating experience in manufacturing or supplying medicinal products, specifically topical preparations. Compliance with health regulations is critical to participate.
What technical specifications must be met for the Diclofenac Diethylamine solution?
The technical specifications require that the solution contains 32% w/v of Diclofenac Diethylamine and is packaged in a 30 ml bottle with a metered dose spray. The product must also comply with all relevant safety and stability regulations.
What are the payment terms associated with this tender?
Payment terms will be outlined in the contract but typically include provisions such as earnest money deposit (EMD) requirements before bid submission, followed by milestone payments upon delivery and acceptance of the products.
How can the submission of documents be carried out for this tender?
The submission of documents must be conducted electronically through the designated e-procurement platform. Bidders should ensure all documents are compiled in PDF format and are complete before submission to avoid disqualification.
Are there any provisions for Micro, Small, and Medium Enterprises (MSEs) in this tender?
Yes, this tender has specific benefits for MSEs, aiming to foster their participation. This includes favorable terms and potential relaxation in certain procedural requirements to encourage small businesses to compete effectively in this procurement process.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 5
GeM-Bidding-7858035.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS